Jacobsen LM, Cuthbertson D, Bundy BN, Atkinson MA, et al. Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes Care 2024 Apr 15:dc240171. doi: 10.2337/dc24-0171.
PMID: 38621411